Intestinal mucosal abnormalities shed light on ‘viral persistence’ of long COVID-19

SAN DIEGO — Patients who recovered from COVID-19 infection demonstrated significant differences in mucosal immune cell populations compared with non-infected controls, according to data presented at Digestive Disease Week 2022.“Our group previously published evidence for the presence of viral proteins in the gut mucosa, not only in patients with acute COVID-19 but also months after recovery, suggesting persistence of virus in the tissue,” Hadar Meringer, MD, of the Icahn School of Medicine at Mount Sinai in New York City, told Healio. “Together with persistence ofRead More

Related Articles